Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

Author:

Kroeger Nils12,Xie Wanling3,Lee Jae-Lyn4,Bjarnason Georg A.5,Knox Jennifer J.6,MacKenzie Mary J.7,Wood Lori8,Srinivas Sandy9,Vaishamayan Ulka N.10,Rha Sun-Young11,Pal Sumanta K.12,Yuasa Takeshi13,Donskov Frede14,Agarwal Neeraj15,Kollmannsberger Christian K.16,Tan Min-Han17,North Scott A.18,Rini Brian I.19,Choueiri Toni K.32021,Heng Daniel Y.C.1

Affiliation:

1. Tom Baker Cancer Center; Calgary Alberta Canada

2. University Medicine Greifswald; Department of Urology; Germany

3. Dana-Farber Cancer Institute; Boston Massachusetts

4. University of Ulsan College of Medicine; Asan South Korea

5. Sunnybrook Odette Cancer Centre; Toronto Ontario Canada

6. Princess Margaret Hospital; University of Toronto; Toronto Ontario Canada

7. London Health Sciences Center; London Ontario Canada

8. Queen Elizabeth II Health Sciences Center; Halifax Nova Scotia Canada

9. Stanford Cancer Institute; Stanford University, School of Medicine; Stanford California

10. Karmanos Cancer Institute; Wayne State University; Detroit Michigan

11. Yonsei Cancer Centre; Yonsei University College of Medicine; Seoul South Korea

12. Department of Medical Oncology and Experimental Therapeutics; City of Hope Comprehensive Cancer Center; Duarte California

13. Departments of Urology; Cancer Institute Hospital, Japanese Foundation for Cancer Research; Tokyo Japan

14. Department of Oncology; Aarhus University Hospital; Aarhus Denmark

15. University of Utah Huntsman Cancer Institute; Salt Lake City Utah

16. Vancouver Cancer Center; British Columbia Cancer Agency; Vancouver British Columbia Canada

17. Department of Medical Oncology; National Cancer Centre and Institute of Bioengineering and Nanotechnology; Singapore

18. Cross Cancer Center; University of Alberta; Edmonton Alberta Canada

19. Taussig Cancer Institute; Cleveland Clinic Foundation; Cleveland Ohio

20. Harvard Medical School; Boston Massachusetts

21. Brigham and Women's Hospital; Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3